1. Home
  2. BOSC vs EVAX Comparison

BOSC vs EVAX Comparison

Compare BOSC & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo B.O.S. Better Online Solutions

BOSC

B.O.S. Better Online Solutions

HOLD

Current Price

$5.05

Market Cap

30.7M

ML Signal

HOLD

EVAX

Evaxion Biotech

HOLD

Current Price

$3.40

Market Cap

31.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOSC
EVAX
Founded
1990
2008
Country
Israel
Denmark
Employees
N/A
N/A
Industry
Computer Communications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.7M
31.9M
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
BOSC
EVAX
Price
$5.05
$3.40
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$11.67
AVG Volume (30 Days)
45.5K
31.7K
Earning Date
03-31-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$8.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.30
$1.20
52 Week High
$6.72
$12.15

Technical Indicators

Market Signals
Indicator
BOSC
EVAX
Relative Strength Index (RSI) 55.15 46.95
Support Level $4.58 $2.45
Resistance Level $5.07 $3.62
Average True Range (ATR) 0.20 0.41
MACD 0.01 -0.01
Stochastic Oscillator 75.73 30.00

Price Performance

Historical Comparison
BOSC
EVAX

About BOSC B.O.S. Better Online Solutions

BOS Better Online Solutions Ltd is a provider of Intelligent Robotics and Supply Chain solutions for enterprises. The company manages its business in three reportable divisions: the Intelligent Robotics segment, the RFID Division segment, and the Supply Chain Solutions segment. The majority of revenue derives from Supply Chain Solutions which distributes electro-mechanical components, mainly to customers in the aerospace, defense, and other industries, and is a supply chain service provider for aviation customers that seek a comprehensive solution to their components-supply needs. Geographically company derives the majority of its revenue from Israel.

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

Share on Social Networks: